Education
About Us
Working with TipRanks
Follow Us
RegeneRx Biopharmaceuticals (RGRX)
OTHER OTC:RGRX
| Dec 22 | Dec 21 | Dec 20 | Dec 19 | Dec 18 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 76.76K | $ 76.76K | $ 76.76K | $ 76.76K | $ 69.67K |
| Gross Profit | $ 76.76K | $ 70.12K | $ 71.84K | $ 76.70K | $ 69.58K |
| Operating Income | $ -1.40M | $ -1.33M | $ -1.29M | $ -1.26M | $ -1.32M |
| EBITDA | $ -1.40M | $ 56.00K | $ -1.29M | $ -1.25M | $ -1.90M |
| Net Income | $ -1.73M | $ -1.60M | $ -1.52M | $ -1.40M | $ -1.99M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 290.89K | $ 1.23M | $ 427.90K | $ 639.92K | $ 237.26K |
| Total Assets | $ 382.18K | $ 1.28M | $ 551.79K | $ 711.76K | $ 281.04K |
| Total Debt | $ 1.45M | $ 1.16M | $ 1.03M | $ 735.08K | $ 54.75K |
| Net Debt | $ 1.16M | $ -66.69K | $ 598.33K | $ 95.17K | $ -182.51K |
| Total Liabilities | $ 3.83M | $ 3.51M | $ 3.38M | $ 3.05M | $ 2.49M |
| Stockholders' Equity | $ -3.45M | $ -2.23M | $ -2.82M | $ -2.34M | $ -2.21M |
| Cash Flow | |||||
| Free Cash Flow | $ -940.72K | $ -990.30K | $ -1.01M | $ -1.14M | $ -888.29K |
| Operating Cash Flow | $ -940.72K | $ -990.30K | $ -1.01M | $ -1.14M | $ -888.29K |
| Investing Cash Flow | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Financing Cash Flow | $ 0.00 | $ 1.79M | $ 794.91K | $ 1.54M | $ 943.85K |
RegeneRx Biopharmaceuticals Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.